Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium
This study has been completed.
Study NCT00309205   Information provided by International Partnership for Microbicides, Inc.

First Received on March 30, 2006.   Last Updated on August 31, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
HIV-1
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
dapivirine (TMC120) vaginal gel
Additional drug interventions recognized in this trial
Anti-Infective Agents
More general drug interventions related to this trial
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
International Partnership for Microbicides, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services